Med Storm Innovation AS

Med Storm Innovation AS develops the PainSensor, an objective nociception monitoring device designed for perioperative anesthesia management and pain assessment. The PainSensor measures skin conductance algesimetry (SCA) to quantify nociceptive response in real time, providing indices for pain perception, awakening depth in unconscious patients, nerve block efficacy, and withdrawal symptoms. The device is based on skin sympathetic nerve activity and acetylcholine signaling, operating independently of temperature, neuromuscular blockers, alpha-2 agonists, epinephrine, beta-blockers, hypoxia, blood volume changes, and perioperative anxiety in conscious patients. Clinical validation spans over 80 peer-reviewed studies demonstrating rapid index response (within seconds) with low inter-individual variation. The PainSensor software integrates with existing multiparameter monitors from Philips and Masimo; Mindray and Draeger integration are in development. The company has received CE Mark (MDR 2017/745 Class IIa), ISO 13485 certification, and has an FDA approval pathway underway. Med Storm has received recognition including Eurostars grants (top 10% of applications), the Society for Technology in Anesthesia award for clinical utility, and Innovation Norway entrepreneur and AstraZeneca pain research prizes. The technology addresses the significant clinical need for objective, quantitative pain monitoring to optimize anesthesia dosing and reduce opioid-related complications.